NCT01691781
The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
See it on ClinicalTrials.gov ↗27 people
40.7%
59.3%
11 womenmiddle line = equal numbers16 men
- Phase
- NA
- Paid for by
- Brigham and Women's Hospital
- Finished
- 2016-12
- Health conditions
- Hyperparathyroidism
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 44.9 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 63% · Black / African American 29.6% · Asian 7.4% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0% · Not reported 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnancy or current breast feeding”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnancy or current breast feeding”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Chronic Kidney Disease or eGFR\<60”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“History of heart failure”
- No diabetes
Women with diabetes were turned away.
“Type 2 Diabetes Mellitus that is not controlled by diet or Metformin alone or with a Hemoglobin A1c \>7.5%”
- No smokers
Women who smoke or use nicotine were turned away.
“Active tobacco or recreational drug use”
Study titles and rules are shown in their original English.